Shares of UTI AMC fell 3.07% to ₹825 on Oct 23, as investors digested a 34.4% sequential decline in Q2 net profit to ₹143 crore.
Revenue slid 23.1% sequentially to ₹337 crore, while core income from services rose 5% quarter‑on‑quarter to ₹324 crore, reflecting a modest uptick against a backdrop of a 23.1% revenue contraction.
EBITDA dipped 35% to ₹195 crore, with the margin tightening from 68.6% in Q1 to 57.9% in Q2 – a 10.7-point erosion that echoes the broader asset‑management squeeze.
In the first half of FY27, UTI AMC’s core income from services rose 1% YoY to ₹632 crore and core profit after tax climbed 14% to ₹253 crore, underscoring a gradual recovery that contrasts sharply with the Q2 slide.
AUM remained robust at ₹4.02 lakh crore (equity 72% of average AUM) and SIP inflows hit ₹2,583 crore, a 7.8% YoY jump, suggesting disciplined investor confidence despite margin pressures.
CEO Vetri Subramaniam said the firm is “strengthening its franchise and expanding investor participation” and highlighted net equity inflows of ₹3,415 crore in H1 FY27, signaling continued growth momentum that may help cushion next‑quarter earnings.
Analysts expect the August–September earnings cycle to see further margin tightening unless core income gains accelerate, with UTI AMC’s next report slated for April 2027.